What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

6 citing papers in PubMed.

1. Quality of life whilst ageing in opioid agonist treatment: a narrative analysis.BMC public health · 2025
   Article
2. Practitioner perspectives on working with older patients in opioid agonist treatment (OAT) in Norway: opportunities and challenges.Addiction science & clinical practice · 2024
   Article
3. Change in self-reported somatic symptoms among patients in opioid maintenance treatment from baseline to 1-year follow-up.BMC psychiatry · 2024
   Article
4. High smoking and low cessation rates among patients in treatment for opioid and other substance use disorders.BMC psychiatry · 2022
   Article
5. Large and non-specific somatic disease burdens among ageing, long-term opioid maintenance treatment patients.Substance abuse treatment, prevention, and policy · 2020
   Article
6. Thematic issue: Substance use and ageing.Nordisk alkohol- & narkotikatidskrift : NAT · 2017
   Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.